Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Anemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    December 2023
  1. MIKI K, Ogasawara R, Sugimura S, Sugita J, et al
    A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.
    Int J Hematol. 2023;118:766-771.
    PubMed     Abstract available


    October 2023
  2. SHINN LT, Benitez LL, Perissinotti AJ, Reid JH, et al
    Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
    Int J Hematol. 2023 Oct 26. doi: 10.1007/s12185-023-03670.
    PubMed     Abstract available


  3. FUKATSU M, Hamazaki Y, Sato Y, Koyama D, et al
    A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Int J Hematol. 2023;118:472-476.
    PubMed     Abstract available


  4. NISHIMURA JI, Kawaguchi T, Ito S, Murai H, et al
    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
    Int J Hematol. 2023;118:419-431.
    PubMed     Abstract available


    September 2023
  5. CHATZIKALIL E, Kattamis A, Diamantopoulos P, Solomou EE, et al
    New-onset aplastic anemia after SARS-CoV-2 vaccination.
    Int J Hematol. 2023 Sep 28. doi: 10.1007/s12185-023-03666.
    PubMed     Abstract available


  6. LI H, Wang J, Wang D, Gan Y, et al
    Ten years' experience in prenatal diagnosis of alpha-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Int J Hematol. 2023;118:355-363.
    PubMed     Abstract available


  7. USUKI K, Ikezoe T, Ishiyama K, Kanda Y, et al
    Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2023;118:311-322.
    PubMed     Abstract available


  8. WANG P, Yang S
    Clonal cytopenia of undetermined significance presenting with multiple duplications of chromosome 1q.
    Int J Hematol. 2023;118:307-308.
    PubMed    


    July 2023
  9. EDAHIRO Y, Ochiai T, Hashimoto Y, Morishita S, et al
    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Int J Hematol. 2023;118:47-53.
    PubMed     Abstract available


    May 2023
  10. KOBAYASHI M, Mori A, Oda Y, Yokoyama E, et al
    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2023 May 23:1-6. doi: 10.1007/s12185-023-03618.
    PubMed     Abstract available


    April 2023
  11. SALES RR, Luizon MR
    Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies.
    Int J Hematol. 2023;117:626-627.
    PubMed    


  12. YAMANO S, Iguchi A, Ishikawa K, Sakamoto A, et al
    Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Int J Hematol. 2023;117:622-625.
    PubMed     Abstract available


  13. SUZUKI Y, Shiba T
    Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination.
    Int J Hematol. 2023;117:618-621.
    PubMed     Abstract available


    March 2023
  14. YOSHIDA N
    Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
    Int J Hematol. 2023 Mar 3. doi: 10.1007/s12185-023-03564.
    PubMed     Abstract available


  15. KUBO M, Matsumoto M
    Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Int J Hematol. 2023;117:331-340.
    PubMed     Abstract available


    February 2023
  16. PIYAJAROENKIJ T, Tantiworawit A, Khikhuntod J, Piriyakhuntorn P, et al
    Alteration of monocyte subsets and their functions in thalassemia patients.
    Int J Hematol. 2023;117:188-197.
    PubMed     Abstract available


    January 2023
  17. KANDA Y, Mori T, Narita A, Wolter KD, et al
    Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
    Int J Hematol. 2023 Jan 25. doi: 10.1007/s12185-023-03543.
    PubMed    


  18. KANDA Y, Usuki K, Inagaki M, Ohta A, et al
    Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
    Int J Hematol. 2023 Jan 3. doi: 10.1007/s12185-022-03530.
    PubMed     Abstract available


    December 2022
  19. STORB R
    Allogeneic bone marrow transplantation for aplastic anemia.
    Int J Hematol. 2022 Dec 28. doi: 10.1007/s12185-022-03506.
    PubMed     Abstract available


    November 2022
  20. KANDA Y, Mori T, Narita A, Wolter KD, et al
    Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
    Int J Hematol. 2022 Nov 28. doi: 10.1007/s12185-022-03496.
    PubMed     Abstract available


  21. NAKAMURA Y, Mori T, Kako S, Yamazaki H, et al
    Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
    Int J Hematol. 2022 Nov 15. pii: 10.1007/s12185-022-03487.
    PubMed     Abstract available


  22. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Nov 8. pii: 10.1007/s12185-022-03485.
    PubMed    


  23. MORITA Y, Nannya Y, Ichikawa M, Hanamoto H, et al
    ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial.
    Int J Hematol. 2022;116:659-668.
    PubMed     Abstract available


  24. LEE FW, Lee CY, Hung GY, Tseng MH, et al
    Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.
    Int J Hematol. 2022;116:812-818.
    PubMed     Abstract available


    September 2022
  25. CHEN CY, Chen TT, Hsieh CY, Lien MY, et al
    Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.
    Int J Hematol. 2022 Sep 4. pii: 10.1007/s12185-022-03445.
    PubMed     Abstract available


    August 2022
  26. CAMASCHELLA C, Pagani A, Silvestri L, Nai A, et al
    The mutual crosstalk between iron and erythropoiesis.
    Int J Hematol. 2022;116:182-191.
    PubMed     Abstract available


  27. MIYAZAKI Y, Kiguchi T, Sato S, Usuki K, et al
    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
    Int J Hematol. 2022;116:228-238.
    PubMed     Abstract available


    July 2022
  28. KAWABATA H, Tamura T, Tamai S, Takahashi T, et al
    Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study.
    Int J Hematol. 2022 Jul 22. pii: 10.1007/s12185-022-03420.
    PubMed     Abstract available


  29. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Jul 6. pii: 10.1007/s12185-022-03401.
    PubMed     Abstract available


  30. KAMURA Y, Sakamoto T, Yokoyama Y, Nishikii H, et al
    Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2022;116:55-59.
    PubMed     Abstract available


  31. SAKAGUCHI H, Yoshida N
    Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2022;116:16-27.
    PubMed     Abstract available


    June 2022
  32. MURAKAMI D, Matsuda K, Honda A, Masamoto Y, et al
    Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia.
    Int J Hematol. 2022 Jun 24. pii: 10.1007/s12185-022-03399.
    PubMed     Abstract available


  33. KAWAKAMI F, Kawakami T, Yamane T, Maruyama M, et al
    T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Int J Hematol. 2022;115:816-825.
    PubMed     Abstract available


    April 2022
  34. JITPIRASAKUN S, Pooliam J, Sriwichakorn C, Sanpakit K, et al
    Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/beta-thalassemia and those achieving successful hematopoietic stem-cell transplantation.
    Int J Hematol. 2022;115:575-584.
    PubMed     Abstract available


  35. IKEZOE T, Noji H, Ueda Y, Kanda Y, et al
    Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan.
    Int J Hematol. 2022;115:470-480.
    PubMed     Abstract available


  36. HAYAMA K, Abe Y, Kamata H, Okina S, et al
    Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.
    Int J Hematol. 2022;115:508-514.
    PubMed     Abstract available


    March 2022
  37. YOUSSRY I, ElGhamrawy M, Seif H, Balsamo L, et al
    Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt.
    Int J Hematol. 2022;115:399-405.
    PubMed     Abstract available


  38. HIDAKA D, Ogasawara R, Sugimura S, Fujii F, et al
    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2022;115:424-427.
    PubMed     Abstract available


    February 2022
  39. SAMPAGAR A, Gosavi M, Kedar P, Patel T, et al
    Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report.
    Int J Hematol. 2022;115:255-262.
    PubMed     Abstract available


    January 2022
  40. ELENGA N, Vantilcke V, Martin E, Cuadro E, et al
    Red blood cell exchange in children with sickle cell disease.
    Int J Hematol. 2022;115:107-113.
    PubMed     Abstract available


    September 2021
  41. WANG Z, Sun W, Chen H, Zhang Y, et al
    Prevalence and molecular spectrum of alpha- and beta-globin gene mutations in Hainan, China.
    Int J Hematol. 2021;114:307-318.
    PubMed     Abstract available


    July 2021
  42. GASIOR KABAT M, Bueno D, Sisinni L, De Paz R, et al
    Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
    Int J Hematol. 2021;114:116-123.
    PubMed     Abstract available


  43. LIU X, Cheng L, He Y, Zhang R, et al
    Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
    Int J Hematol. 2021;114:124-128.
    PubMed     Abstract available


  44. JANOWIAK-MAJERANOWSKA A, Majeranowski A
    Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;114:147-148.
    PubMed    


    June 2021
  45. YOSHINARI H, Kawahara Y, Niijima H, Oh Y, et al
    Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
    Int J Hematol. 2021 Jun 10. pii: 10.1007/s12185-021-03165.
    PubMed     Abstract available


    May 2021
  46. MAHE K, Couturaud F, Kerspern H, Chauveau A, et al
    Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
    Int J Hematol. 2021 May 22. pii: 10.1007/s12185-021-03164.
    PubMed     Abstract available


    April 2021
  47. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    PubMed     Abstract available


  48. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.
    PubMed    


  49. LERTKOVIT O, Anurathapan U, Hongeng S, Thokanit NS, et al
    Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:556-565.
    PubMed     Abstract available


    March 2021
  50. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    PubMed     Abstract available


  51. OTSUKA H, Endo Y, Ohtsu H, Inoue S, et al
    Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.
    Int J Hematol. 2021;113:348-361.
    PubMed     Abstract available


    February 2021
  52. VIVES-CORRONS JL, Krishnevskaya E, Rodriguez IH, Ancochea A, et al
    Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
    Int J Hematol. 2021;113:163-174.
    PubMed     Abstract available


  53. PINCZES LI, Szabo R, Miltenyi Z, Illes A, et al
    The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int J Hematol. 2021;113:175-182.
    PubMed     Abstract available


    January 2021
  54. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    PubMed     Abstract available


  55. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    PubMed     Abstract available


    December 2020
  56. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    PubMed     Abstract available


    October 2020
  57. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    PubMed     Abstract available


  58. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    PubMed     Abstract available


    September 2020
  59. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    PubMed     Abstract available


    June 2020
  60. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    PubMed     Abstract available


    May 2020
  61. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.